Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "financial results" return 52 results.
Ceva uses creative thinking in new approach to innovation in Industrial equity >
Libourne, France 2nd May 2013: Most of the time innovation in the bio-pharmaceutical field is associated with the scientific R&D teams. But having the latest technology vaccines is of little value i...
Ceva Welfare Awards – Winners announcement >
2nd Annual Ceva Animal Welfare Awards, celebrating the contributions to the prevention and reduction of animal welfare problems in the UK and abroad.
Ceva records double digit growth for 3rd. successive year >
14% growth pushes sales beyond 600 M€ for first time
AXA Private Equity provides additional financing to support the development of Ceva >
AXA Private Equity, the leading European diversified private equity firm, announces today that it is providing €100 million of additional financing to support the development of Ceva.
Ceva conducts Global Vaccine Symposium - 2010, October 6-8th >
Do new technologies go with better poultry production and better global health ?
The Perfect Pair is now available >
A great innovation in the protection against Newcastle and Gumboro Diseases
Ceva launches CARDALIS® for dogs with heart failure >
A powerful dual treatment in a single tablet
Mid-year results : Innovation drives Ceva’s growth >
Double-digit growth confirms long term upward trend
Ceva sponsors 8th International Symposium on Avian Influenza >
Innovation in poultry vaccines and solutions reaches beyond animal health
New commercial licenses for viral vaccine production >
Ceva takes commercial license for ProBioGen’s AGE1.CR® Cell Line for viral vaccine production